Attached files
| file | filename |
|---|---|
| EX-10.17 - AMENDED AND RESTATED AMERCIAN BRIVISION (HOLDING) CORPORATION 2016 EQUITY INCENT - ABVC BIOPHARMA, INC. | f10k2020ex10-17_americanbriv.htm |
| EX-32.2 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2020ex32-2_americanbriv.htm |
| EX-32.1 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2020ex32-1_americanbriv.htm |
| EX-31.2 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2020ex31-2_americanbriv.htm |
| EX-31.1 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2020ex31-1_americanbriv.htm |
| EX-4.2 - DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT - ABVC BIOPHARMA, INC. | f10k2020ex4-2_americanbriv.htm |
| 10-K - ANNUAL REPORT - ABVC BIOPHARMA, INC. | f10k2020_americanbrivi.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement Nos. 333-234656, 333-209577 and 333-158508 on Forms S-8 of our report dated March 15, 2021, relating to the consolidated financial statements of American BriVision (Holding) Corporation and subsidiaries in this Annual Report on Form 10-K of American BriVision (Holding) Corporation and subsidiaries for the year ended December 31, 2020.
| /s/ KCCW Accountancy Corp. | |
|
Diamond Bar, California March 15, 2021 |
KCCW Accountancy Corp. 3333 S. Brea Canyon Road, Suite 206, CA 91765 USA
Tel: +1 909 348 7228 • Fax: +1 909 895 4155